|Bid||15.60 x 800|
|Ask||16.39 x 1100|
|Day's Range||15.77 - 16.43|
|52 Week Range||6.51 - 37.99|
|Beta (5Y Monthly)||1.10|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
It is doubtless a positive to see that the Deciphera Pharmaceuticals, Inc. ( NASDAQ:DCPH ) share price has gained some...
Deciphera (DCPH) reports a narrower-than-expected loss in the second quarter of 2022 while revenues beat estimates. Shares rise.
Deciphera Pharmaceuticals, Inc. (DCPH) delivered earnings and revenue surprises of 7.69% and 7.56%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?